With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and... @cosmicmeta.ai #Acq
https://u2m.io/gGL2bd6K